F H Cornelis1, K Kim2, J C Durack1, S Jebiwott2, A Scherz3, G Srimathveeravalli4, J A Coleman5. 1. Interventional Radiology Service, Department of Radiology, Memorial Sloan-Kettering Cancer Center,1275 York Avenue, New York, NY 10065, USA; Urology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA; Plant Science, Weizmann Institute of Science, Rehovot, Israel. 2. Urology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA; Plant Science, Weizmann Institute of Science, Rehovot, Israel. 3. Plant Science, Weizmann Institute of Science, Rehovot, Israel. 4. Interventional Radiology Service, Department of Radiology, Memorial Sloan-Kettering Cancer Center,1275 York Avenue, New York, NY 10065, USA. Electronic address: srimaths@mskcc.org. 5. Plant Science, Weizmann Institute of Science, Rehovot, Israel. Electronic address: colemanj@mskcc.org.
Abstract
AIMS: To evaluate the accuracy of contrast-enhanced ultrasound (CEUS) for monitoring tumor necrosis following WST-11 vascular targeted photodynamic therapy (VTP) using imaging-pathology correlation. METHODS: Renal adenocarcinoma cells were injected into the hindlimb of 13 BalB/c mice resulting in tumors ranging from 9.8 to 194.3mm3. US guidance was used to place a laser fiber into the tumor, and VTP was performed. CEUS was performed prior to animal sacrifice, 24h post-VTP. Whole tumors were extracted for histopathologic analysis using H&E and TUNEL staining. Pathology samples corresponding to the CEUS imaging plane were prepared in order to compare the size and extents of tumor necrosis. RESULTS: Tumor necrosis following VTP appeared as a central region of non-enhancement on CEUS, while viable tumor appeared as patchy regions of enhancement in the tumor periphery. The region of tumor necrosis measured in mean 66% and 64.8% of total tumor area on CEUS and pathology respectively (p=0.2). The size and location of the necrosis on CEUS images and pathology samples were found correlative with no inter-observer difference (weighted kappa of 0.771 and 0.823, respectively). CONCLUSION: CEUS allows accurate monitoring of VTP induced tumor necrosis in a small animal model.
AIMS: To evaluate the accuracy of contrast-enhanced ultrasound (CEUS) for monitoring tumor necrosis following WST-11 vascular targeted photodynamic therapy (VTP) using imaging-pathology correlation. METHODS:Renal adenocarcinoma cells were injected into the hindlimb of 13 BalB/c mice resulting in tumors ranging from 9.8 to 194.3mm3. US guidance was used to place a laser fiber into the tumor, and VTP was performed. CEUS was performed prior to animal sacrifice, 24h post-VTP. Whole tumors were extracted for histopathologic analysis using H&E and TUNEL staining. Pathology samples corresponding to the CEUS imaging plane were prepared in order to compare the size and extents of tumor necrosis. RESULTS:Tumor necrosis following VTP appeared as a central region of non-enhancement on CEUS, while viable tumor appeared as patchy regions of enhancement in the tumor periphery. The region of tumor necrosis measured in mean 66% and 64.8% of total tumor area on CEUS and pathology respectively (p=0.2). The size and location of the necrosis on CEUS images and pathology samples were found correlative with no inter-observer difference (weighted kappa of 0.771 and 0.823, respectively). CONCLUSION: CEUS allows accurate monitoring of VTP induced tumor necrosis in a small animal model.
Authors: Shashank R Sirsi; Molly L Flexman; Fotois Vlachos; Jianzhong Huang; Sonia L Hernandez; Hyun Keol Kim; Tessa B Johung; Jeffrey W Gander; Ari R Reichstein; Brooke S Lampl; Antai Wang; Andreas H Hielscher; Jessica J Kandel; Darrell J Yamashiro; Mark A Borden Journal: Ultrasound Med Biol Date: 2012-03-16 Impact factor: 2.998
Authors: Simon Y Kimm; Tatum V Tarin; Sébastien Monette; Govindarajan Srimathveeravalli; Daniel Gerber; Jeremy C Durack; Stephen B Solomon; Peter T Scardino; Avigdor Scherz; Jonathan Coleman Journal: Radiology Date: 2016-03-17 Impact factor: 11.105
Authors: M Medinger; N Esser; J Soltau; K M Lehmann; M A Konerding; T Wolloscheck; A J Ryan; J Drevs Journal: Int J Oncol Date: 2010-12-07 Impact factor: 5.650
Authors: Axel Bex; Laure Fournier; Nathalie Lassau; Peter Mulders; Paul Nathan; Wim J G Oyen; Thomas Powles Journal: Eur Urol Date: 2013-11-28 Impact factor: 20.096
Authors: Lucas Nogueira; Andrew T Tracey; Ricardo Alvim; Peter Reisz; Avigdor Scherz; Jonathan A Coleman; Kwanghee Kim Journal: Molecules Date: 2020-11-19 Impact factor: 4.411